Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Liping Yu

Concepts (257)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Autoantibodies
55
2026
1501
5.570
 Why?
Diabetes Mellitus, Type 1
59
2026
3890
3.600
 Why?
Luminescent Measurements
7
2021
76
2.850
 Why?
Celiac Disease
8
2023
308
2.200
 Why?
Islets of Langerhans
23
2026
833
2.110
 Why?
Glutamate Decarboxylase
15
2022
165
1.850
 Why?
Electrochemical Techniques
4
2021
55
1.680
 Why?
High-Throughput Screening Assays
3
2020
175
1.510
 Why?
Zinc Transporter 8
11
2026
70
1.390
 Why?
Autoimmune Diseases
5
2020
463
1.290
 Why?
Transglutaminases
6
2023
159
1.220
 Why?
Mass Screening
11
2021
1347
1.170
 Why?
Insulin Antibodies
10
2016
103
1.150
 Why?
Prediabetic State
6
2015
245
1.080
 Why?
Cation Transport Proteins
8
2013
118
1.050
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 8
6
2016
54
0.940
 Why?
Insulin
20
2021
2507
0.870
 Why?
Proinsulin
4
2016
51
0.870
 Why?
Sensitivity and Specificity
14
2022
1985
0.850
 Why?
Diagnostic Techniques, Endocrine
3
2019
14
0.660
 Why?
Autoantigens
7
2021
429
0.630
 Why?
Antibodies, Viral
2
2023
672
0.530
 Why?
Autoimmunity
12
2023
926
0.510
 Why?
Child, Preschool
25
2023
11787
0.450
 Why?
Child
33
2026
22633
0.440
 Why?
Biomarkers
7
2022
4271
0.410
 Why?
Glucose Intolerance
1
2015
142
0.400
 Why?
Adolescent
29
2026
22428
0.380
 Why?
Infant
19
2023
10034
0.380
 Why?
Humans
64
2026
144759
0.370
 Why?
Luminescence
4
2016
39
0.360
 Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
97
0.340
 Why?
Peptide Fragments
8
2016
699
0.310
 Why?
Male
31
2026
72315
0.300
 Why?
Young Adult
14
2026
14105
0.300
 Why?
Female
35
2026
78271
0.290
 Why?
Immunologic Factors
1
2011
255
0.290
 Why?
Protein Precursors
3
2021
137
0.290
 Why?
Diabetes Mellitus, Type 2
3
2022
2583
0.290
 Why?
Radioimmunoassay
4
2016
165
0.280
 Why?
Quality Improvement
1
2017
1289
0.280
 Why?
Radioligand Assay
2
2009
37
0.280
 Why?
Adult
19
2026
40449
0.270
 Why?
Antibodies, Antinuclear
1
2007
62
0.260
 Why?
Reagent Kits, Diagnostic
1
2007
34
0.250
 Why?
Disease Progression
9
2019
2847
0.240
 Why?
Risk Factors
10
2021
10779
0.230
 Why?
Nephrotic Syndrome
1
2026
44
0.230
 Why?
Seroepidemiologic Studies
3
2023
172
0.230
 Why?
Insulin-Secreting Cells
3
2019
388
0.220
 Why?
Podocytes
1
2026
80
0.220
 Why?
Addison Disease
3
2012
38
0.220
 Why?
Middle Aged
13
2026
35875
0.210
 Why?
Lupus Erythematosus, Systemic
1
2007
239
0.210
 Why?
CD4-Positive T-Lymphocytes
4
2021
1129
0.200
 Why?
Enzyme-Linked Immunosorbent Assay
5
2011
851
0.200
 Why?
Membrane Glycoproteins
1
2026
496
0.190
 Why?
Case-Control Studies
3
2021
3604
0.190
 Why?
Isoenzymes
2
2004
299
0.180
 Why?
Disease Susceptibility
2
2020
348
0.180
 Why?
Electrochemistry
1
2021
73
0.180
 Why?
Genotype
9
2016
1833
0.170
 Why?
Interleukin 1 Receptor Antagonist Protein
1
2022
253
0.170
 Why?
China
1
2021
269
0.170
 Why?
Predictive Value of Tests
6
2015
2115
0.160
 Why?
Polymorphism, Genetic
4
2017
612
0.160
 Why?
GTP-Binding Proteins
1
2021
153
0.160
 Why?
DNA
1
2007
1463
0.160
 Why?
Spike Glycoprotein, Coronavirus
1
2021
130
0.150
 Why?
Steroid 21-Hydroxylase
3
2012
27
0.150
 Why?
Health Fairs
1
2019
10
0.150
 Why?
Follow-Up Studies
6
2021
5408
0.150
 Why?
Endothelial Cells
1
2026
869
0.150
 Why?
Risk Assessment
3
2020
3671
0.140
 Why?
Colorado
4
2023
4564
0.140
 Why?
Phosphoproteins
1
2021
344
0.140
 Why?
Prognosis
5
2021
4282
0.140
 Why?
Prevalence
3
2023
2834
0.140
 Why?
Epitopes
4
2021
485
0.140
 Why?
Receptors, Antigen, T-Cell
2
2023
668
0.130
 Why?
Polyendocrinopathies, Autoimmune
1
2017
18
0.130
 Why?
Antibody Specificity
4
2011
181
0.130
 Why?
Cohort Studies
3
2021
5960
0.130
 Why?
Population Surveillance
1
2020
485
0.130
 Why?
Mice, Inbred NOD
8
2008
610
0.130
 Why?
Disease Management
1
2020
645
0.120
 Why?
Health Care Costs
1
2020
427
0.120
 Why?
Age of Onset
4
2026
551
0.120
 Why?
T-Lymphocytes
5
2023
1982
0.120
 Why?
HLA-DQ Antigens
5
2016
173
0.120
 Why?
Aged
6
2026
25913
0.120
 Why?
Risk
2
2019
911
0.110
 Why?
Hematopoietic Stem Cell Transplantation
1
2020
675
0.110
 Why?
Incidence
1
2021
2879
0.110
 Why?
Transcription Factors
2
2017
1741
0.100
 Why?
Protein Tyrosine Phosphatases
3
2004
167
0.100
 Why?
Poly I-C
2
2004
57
0.100
 Why?
Biopsy
1
2016
1075
0.100
 Why?
Reproducibility of Results
2
2019
3409
0.090
 Why?
Prospective Studies
6
2023
7990
0.090
 Why?
Histocompatibility Antigens Class I
3
2009
202
0.090
 Why?
HLA-DR Antigens
4
2016
220
0.090
 Why?
Iodine Radioisotopes
1
2011
136
0.080
 Why?
Pedigree
3
2017
514
0.080
 Why?
Mice
15
2026
18339
0.080
 Why?
Glucose Tolerance Test
1
2012
361
0.080
 Why?
Rituximab
1
2011
209
0.080
 Why?
HLA-DR4 Antigen
3
2011
74
0.080
 Why?
HLA-DR3 Antigen
3
2011
76
0.080
 Why?
Drug Administration Schedule
1
2011
779
0.070
 Why?
Animals
16
2026
38058
0.070
 Why?
Laboratories
1
2009
109
0.070
 Why?
Interferon-alpha
2
2009
197
0.070
 Why?
Longitudinal Studies
3
2021
2947
0.070
 Why?
Radioimmunoprecipitation Assay
1
2007
6
0.070
 Why?
Antibody Formation
1
2008
294
0.060
 Why?
Diagnosis, Differential
1
2011
1489
0.060
 Why?
Histocompatibility Antigens
1
2008
102
0.060
 Why?
Family
1
2012
679
0.060
 Why?
Peptides
2
2023
995
0.060
 Why?
Recombinant Fusion Proteins
1
2009
675
0.060
 Why?
Double-Blind Method
1
2011
2029
0.060
 Why?
Membrane Proteins
2
2004
1166
0.060
 Why?
CD4 Antigens
2
2003
139
0.060
 Why?
Integrin beta1
1
2026
33
0.060
 Why?
Proteinuria
1
2026
102
0.060
 Why?
C-Peptide
2
2016
189
0.060
 Why?
Receptors, Complement
1
2026
125
0.060
 Why?
Kidney Glomerulus
1
2026
128
0.060
 Why?
Anaphylaxis
2
2004
102
0.050
 Why?
Transforming Growth Factor beta1
1
2026
178
0.050
 Why?
Antibodies, Heterophile
1
2004
13
0.050
 Why?
Twins, Dizygotic
1
2004
109
0.050
 Why?
Models, Biological
1
2011
1821
0.050
 Why?
Mice, Knockout
3
2026
3121
0.050
 Why?
Siblings
1
2004
195
0.050
 Why?
Mice, Inbred BALB C
5
2004
1253
0.050
 Why?
Endocrine System Diseases
1
2004
35
0.050
 Why?
Immunity, Mucosal
1
2004
98
0.050
 Why?
Doxorubicin
1
2026
397
0.050
 Why?
Glycolipids
1
2004
52
0.050
 Why?
Remission Induction
1
2004
307
0.050
 Why?
Immunoglobulin E
2
2021
315
0.050
 Why?
Genetic Testing
1
2005
478
0.050
 Why?
Osteopontin
1
2022
34
0.050
 Why?
Fetal Blood
1
2004
342
0.040
 Why?
Epitopes, B-Lymphocyte
1
2021
20
0.040
 Why?
Diagnostic Techniques, Radioisotope
1
2021
9
0.040
 Why?
Seroconversion
1
2021
49
0.040
 Why?
Immunoglobulin D
1
2021
29
0.040
 Why?
Serologic Tests
1
2021
53
0.040
 Why?
Canada
1
2002
428
0.040
 Why?
Polymorphism, Single Nucleotide
1
2008
2145
0.040
 Why?
Diabetes Mellitus, Experimental
1
2002
198
0.040
 Why?
Multicenter Studies as Topic
1
2002
405
0.040
 Why?
Asymptomatic Diseases
1
2021
102
0.040
 Why?
Immunoglobulin G
2
2021
893
0.040
 Why?
Quality-Adjusted Life Years
1
2020
121
0.040
 Why?
Immunoglobulin M
1
2021
284
0.040
 Why?
Blood Specimen Collection
1
2019
38
0.040
 Why?
Immunoglobulin A
1
2021
214
0.040
 Why?
Infant, Newborn
4
2005
6429
0.040
 Why?
Costs and Cost Analysis
1
2020
219
0.040
 Why?
Age Factors
2
2004
3333
0.040
 Why?
Early Diagnosis
1
2020
249
0.040
 Why?
Methylation
1
2019
242
0.040
 Why?
Adrenocorticotropic Hormone
2
2012
147
0.030
 Why?
Proportional Hazards Models
2
2016
1325
0.030
 Why?
Alleles
3
2009
879
0.030
 Why?
Loss of Function Mutation
1
2017
46
0.030
 Why?
Tissue Donors
1
2021
424
0.030
 Why?
Cell Death
1
2019
383
0.030
 Why?
Community Health Services
1
2019
233
0.030
 Why?
Diabetic Ketoacidosis
1
2020
210
0.030
 Why?
Cost-Benefit Analysis
1
2020
634
0.030
 Why?
Clinical Trials as Topic
1
2002
1053
0.030
 Why?
Mice, Transgenic
3
2008
2182
0.030
 Why?
Hydrocortisone
2
2012
304
0.030
 Why?
Phenotype
2
2021
3162
0.030
 Why?
HLA-DQ beta-Chains
2
2009
57
0.030
 Why?
Antibodies, Monoclonal
1
2003
1519
0.030
 Why?
Cross-Sectional Studies
2
2023
5868
0.030
 Why?
Oligonucleotide Array Sequence Analysis
2
2008
758
0.030
 Why?
Antibody Affinity
1
2016
60
0.030
 Why?
Time Factors
3
2016
7173
0.030
 Why?
Protein Domains
1
2017
313
0.030
 Why?
Polymerase Chain Reaction
2
2009
1054
0.030
 Why?
Organ Specificity
2
2007
312
0.030
 Why?
Genome-Wide Association Study
1
2022
1406
0.030
 Why?
Proteomics
1
2022
1195
0.030
 Why?
Blood Glucose
3
2016
2327
0.030
 Why?
HEK293 Cells
1
2017
744
0.030
 Why?
Injections, Subcutaneous
2
2004
164
0.030
 Why?
Adoptive Transfer
2
2005
198
0.030
 Why?
Mice, SCID
2
2005
369
0.020
 Why?
Protein Tyrosine Phosphatase, Non-Receptor Type 1
2
2004
44
0.020
 Why?
Multivariate Analysis
1
2016
1539
0.020
 Why?
Renin
1
2012
34
0.020
 Why?
Spleen
2
2005
508
0.020
 Why?
Signal Transduction
1
2026
5226
0.020
 Why?
Administration, Oral
2
2004
847
0.020
 Why?
Enzyme-Linked Immunospot Assay
1
2011
37
0.020
 Why?
Immunization
2
2004
374
0.020
 Why?
Feasibility Studies
1
2015
1095
0.020
 Why?
Hypoglycemic Agents
1
2020
1387
0.020
 Why?
Graves Disease
1
2009
30
0.020
 Why?
Homozygote
1
2009
199
0.020
 Why?
HLA-DRB1 Chains
1
2009
109
0.020
 Why?
Microsatellite Repeats
1
2009
157
0.020
 Why?
International Cooperation
1
2009
198
0.020
 Why?
Retrospective Studies
1
2026
17066
0.020
 Why?
Interferon-gamma
1
2011
784
0.020
 Why?
Pediatrics
1
2015
1114
0.020
 Why?
ROC Curve
1
2009
614
0.020
 Why?
Age Distribution
1
2007
403
0.020
 Why?
Metabolic Networks and Pathways
1
2008
187
0.020
 Why?
Thyroglobulin
1
2005
29
0.010
 Why?
Rats
2
2004
5597
0.010
 Why?
Iodide Peroxidase
1
2005
34
0.010
 Why?
Integrin alpha Chains
1
2004
22
0.010
 Why?
Family Health
1
2005
191
0.010
 Why?
Histocompatibility Testing
1
2004
121
0.010
 Why?
B7-1 Antigen
1
2004
55
0.010
 Why?
False Positive Reactions
1
2004
121
0.010
 Why?
United States
1
2002
15966
0.010
 Why?
Endocrine System
1
2004
22
0.010
 Why?
HLA Antigens
1
2005
225
0.010
 Why?
Single-Blind Method
1
2004
312
0.010
 Why?
Disease Models, Animal
2
2004
4557
0.010
 Why?
Cyclophosphamide
1
2003
266
0.010
 Why?
T-Box Domain Proteins
1
2003
106
0.010
 Why?
Species Specificity
1
2004
574
0.010
 Why?
Enkephalins
1
2002
21
0.010
 Why?
Delivery, Obstetric
1
2004
160
0.010
 Why?
Pyridinium Compounds
1
2002
31
0.010
 Why?
Reference Values
1
2004
797
0.010
 Why?
CD8 Antigens
1
2002
72
0.010
 Why?
HLA-A Antigens
1
2002
52
0.010
 Why?
Mice, Inbred C57BL
2
2004
5992
0.010
 Why?
Models, Immunological
1
2002
100
0.010
 Why?
Chronic Disease
1
2008
1813
0.010
 Why?
Gene Expression Profiling
1
2008
1782
0.010
 Why?
Antigens, CD
1
2004
555
0.010
 Why?
Antibodies
1
2003
401
0.010
 Why?
Major Histocompatibility Complex
1
2002
229
0.010
 Why?
Regression Analysis
1
2004
1003
0.010
 Why?
Glucagon
1
2002
112
0.010
 Why?
Cells, Cultured
1
2008
4154
0.010
 Why?
Histocompatibility Antigens Class II
1
2002
364
0.010
 Why?
Survival Analysis
1
2003
1382
0.010
 Why?
Amino Acid Sequence
1
2004
2155
0.010
 Why?
Genetic Predisposition to Disease
1
2008
2363
0.010
 Why?
Proteins
1
2004
1021
0.010
 Why?
Immunity, Innate
1
2004
846
0.010
 Why?
Immunohistochemistry
1
2002
1716
0.010
 Why?
Vaccination
1
2003
1423
0.010
 Why?
Pregnancy
1
2004
7190
0.010
 Why?
Yu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (257) concept(s)
_
Co-Authors Expand Description
See all (38) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)